671 related articles for article (PubMed ID: 16385450)
21. An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN.
Lorson CL; Androphy EJ
Hum Mol Genet; 2000 Jan; 9(2):259-65. PubMed ID: 10607836
[TBL] [Abstract][Full Text] [Related]
22. The splicing regulator Sam68 binds to a novel exonic splicing silencer and functions in SMN2 alternative splicing in spinal muscular atrophy.
Pedrotti S; Bielli P; Paronetto MP; Ciccosanti F; Fimia GM; Stamm S; Manley JL; Sette C
EMBO J; 2010 Apr; 29(7):1235-47. PubMed ID: 20186123
[TBL] [Abstract][Full Text] [Related]
23. Stimulating full-length SMN2 expression by delivering bifunctional RNAs via a viral vector.
Baughan T; Shababi M; Coady TH; Dickson AM; Tullis GE; Lorson CL
Mol Ther; 2006 Jul; 14(1):54-62. PubMed ID: 16580882
[TBL] [Abstract][Full Text] [Related]
24. Molecular and functional analysis of intragenic SMN1 mutations in patients with spinal muscular atrophy.
Sun Y; Grimmler M; Schwarzer V; Schoenen F; Fischer U; Wirth B
Hum Mutat; 2005 Jan; 25(1):64-71. PubMed ID: 15580564
[TBL] [Abstract][Full Text] [Related]
25. Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice.
Hua Y; Vickers TA; Okunola HL; Bennett CF; Krainer AR
Am J Hum Genet; 2008 Apr; 82(4):834-48. PubMed ID: 18371932
[TBL] [Abstract][Full Text] [Related]
26. Regulation of murine survival motor neuron (Smn) protein levels by modifying Smn exon 7 splicing.
DiDonato CJ; Lorson CL; De Repentigny Y; Simard L; Chartrand C; Androphy EJ; Kothary R
Hum Mol Genet; 2001 Nov; 10(23):2727-36. PubMed ID: 11726560
[TBL] [Abstract][Full Text] [Related]
27. An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA.
Zhang ML; Lorson CL; Androphy EJ; Zhou J
Gene Ther; 2001 Oct; 8(20):1532-8. PubMed ID: 11704813
[TBL] [Abstract][Full Text] [Related]
28. Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts.
Skordis LA; Dunckley MG; Yue B; Eperon IC; Muntoni F
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4114-9. PubMed ID: 12642665
[TBL] [Abstract][Full Text] [Related]
29. Restoration of SMN function: delivery of a trans-splicing RNA re-directs SMN2 pre-mRNA splicing.
Coady TH; Shababi M; Tullis GE; Lorson CL
Mol Ther; 2007 Aug; 15(8):1471-8. PubMed ID: 17551501
[TBL] [Abstract][Full Text] [Related]
30. In vivo selection reveals combinatorial controls that define a critical exon in the spinal muscular atrophy genes.
Singh NN; Androphy EJ; Singh RN
RNA; 2004 Aug; 10(8):1291-305. PubMed ID: 15272122
[TBL] [Abstract][Full Text] [Related]
31. Modulating role of RNA structure in alternative splicing of a critical exon in the spinal muscular atrophy genes.
Singh NN; Singh RN; Androphy EJ
Nucleic Acids Res; 2007; 35(2):371-89. PubMed ID: 17170000
[TBL] [Abstract][Full Text] [Related]
32. The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells.
Riessland M; Brichta L; Hahnen E; Wirth B
Hum Genet; 2006 Aug; 120(1):101-10. PubMed ID: 16724231
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.
Thurmond J; Butchbach ME; Palomo M; Pease B; Rao M; Bedell L; Keyvan M; Pai G; Mishra R; Haraldsson M; Andresson T; Bragason G; Thosteinsdottir M; Bjornsson JM; Coovert DD; Burghes AH; Gurney ME; Singh J
J Med Chem; 2008 Feb; 51(3):449-69. PubMed ID: 18205293
[TBL] [Abstract][Full Text] [Related]
34. Targeting SR proteins improves SMN expression in spinal muscular atrophy cells.
Wee CD; Havens MA; Jodelka FM; Hastings ML
PLoS One; 2014; 9(12):e115205. PubMed ID: 25506695
[TBL] [Abstract][Full Text] [Related]
35. A multi-exon-skipping detection assay reveals surprising diversity of splice isoforms of spinal muscular atrophy genes.
Singh NN; Seo J; Rahn SJ; Singh RN
PLoS One; 2012; 7(11):e49595. PubMed ID: 23185376
[TBL] [Abstract][Full Text] [Related]
36. Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts.
Mattis VB; Rai R; Wang J; Chang CW; Coady T; Lorson CL
Hum Genet; 2006 Nov; 120(4):589-601. PubMed ID: 16951947
[TBL] [Abstract][Full Text] [Related]
37. Spinal muscular atrophy: from gene to therapy.
Wirth B; Brichta L; Hahnen E
Semin Pediatr Neurol; 2006 Jun; 13(2):121-31. PubMed ID: 17027862
[TBL] [Abstract][Full Text] [Related]
38. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2.
Monani UR; Lorson CL; Parsons DW; Prior TW; Androphy EJ; Burghes AH; McPherson JD
Hum Mol Genet; 1999 Jul; 8(7):1177-83. PubMed ID: 10369862
[TBL] [Abstract][Full Text] [Related]
39. Robust quantification of the SMN gene copy number by real-time TaqMan PCR.
Gómez-Curet I; Robinson KG; Funanage VL; Crawford TO; Scavina M; Wang W
Neurogenetics; 2007 Nov; 8(4):271-8. PubMed ID: 17647030
[TBL] [Abstract][Full Text] [Related]
40. Putting some spine into alternative splicing.
Khoo B; Akker SA; Chew SL
Trends Biotechnol; 2003 Aug; 21(8):328-30. PubMed ID: 12902166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
